Saturday July 20, 2019

New biomarker for breast and prostate cancers found

0
//

cancer-390322_640

New York : Researchers have identified a novel genetic biomarker responsible for the progression of many breast and prostate cancers.

The finding could bolster efforts to better identify patients who respond to certain types of chemotherapy drugs that attack the most aggressive forms of cancer.

“Understanding and identifying biomarkers is a vital step toward cancer research and care,” said lead study author Michael Freeman from Cedars-Sinai Medical Centre in Los Angeles, California, US.

“New profiling strategies exemplified by this study will ultimately improve our ability to treat cancer patients,” Freeman noted.

The newly identified genetic biomarker – diaphanous- related formin-3 or DIAPH3 – participates in a protein interaction that makes cells rigid.

The study found that when this biomarker is lost or lowered, cells become “deformable,” squeezing through tissue spaces, causing disease growth or progression.

The study was published in the journal Scientific Reports.

(IANS)

 

 

Next Story

New Reusable Device Which can Help Women with Breast Cancer in Lower-Income Countries

Innovation in cancer care doesn't always mean that you have to create an entirely new treatment

0
Breast Cancer, Device, Women
According to the study published in the journal PLOS One, the research team wanted to create a tissue-freezing tool that uses carbon dioxide. Pixabay

Researchers have developed a new reusable device which can help women with breast cancer in lower-income countries by using carbon dioxide, a widely available and affordable gas, to power a cancer tissue-freezing probe instead of industry-standard argon.

According to the study published in the journal PLOS One, the research team wanted to create a tissue-freezing tool that uses carbon dioxide, which is already widely available in most rural areas thanks to the popularity of carbonated drinks.

“Innovation in cancer care doesn’t always mean that you have to create an entirely new treatment. Sometimes it means radically innovating on proven therapies such that they’re redesigned to be accessible to the majority of the world’s population,” said the study’s first author Bailey Surtees from the Johns Hopkins University.

For the study, the research team tested their tool in three experiments to ensure it could remain cold enough in conditions similar to the human breast and successfully kill tumour tissues.

Breast Cancer, Device, Women
Researchers have developed a new reusable device which can help women with breast cancer in lower-income countries by using carbon dioxide. Pixabay

In the first experiment, the team used the tool on jars of ultrasound gel, which thermodynamically mimics human breast tissue, to determine whether it could successfully reach standard freezing temperatures killing tissues and form consistent iceballs.

In all the trials, the device formed large enough iceballs and reached temperatures below -40 degrees Celsius, which meets standard freezing temperatures for tissue death for similar devices in the United States.

For the second experiment, the team treated 9 rats with 10 mammary tumours. Afterwards, they looked at the tissues under a microscope and confirmed that the tool successfully killed 85 per cent or more tissues for all tumours.

Finally, the team tested the tool’s ability to reach temperatures cold enough for tissue destruction in the normal liver of a pig, which has a temperature similar to a human breast.

Also Read- Bitcoin Slumps More than 10% as Fears of Crackdown of Cryptocurrencies Grew

The device was successfully able to stay cold enough during the entire experiment to kill the target tissue. (IANS)